Kim Kelderman Power - 15 Aug 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Aug 2022, 17:25:16 UTC
Prior SEC filing
09 Aug 2022
Next SEC filing
25 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brenda S. Furlow, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed

Key filing fact

Kim Kelderman Power filed Form 4 for BIO-TECHNE Corp (TECH) on 17 Aug 2022.

Key facts

  • This page summarizes Kim Kelderman Power's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 3 reported transactions and 16 derivative rows are listed below.
  • Accepted by SEC: 17 Aug 2022, 17:25.

Change

  • Previous filing in this sequence was filed on 09 Aug 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,138
Date
15 Aug 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+1,746
Change %
Price
$0.000000
Shares after
1,746
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,746
Exercise price
Footnotes
F1, F2
TECH transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value
$0
Shares
+5,426
Change %
Price
$0.000000
Shares after
5,426
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,426
Exercise price
$378.08
Footnotes
F2
TECH transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value
$0
Shares
+7,235
Change %
Price
$0.000000
Shares after
7,235
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,235
Exercise price
$378.08
Footnotes
F3
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,511
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,511
Exercise price
$150.78
Footnotes
F4
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,044
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,044
Exercise price
$177.32
Footnotes
F5
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,033
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,033
Exercise price
$177.32
Footnotes
F6
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,961
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,961
Exercise price
$190.41
Footnotes
F7
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,948
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,948
Exercise price
$190.41
Footnotes
F8
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,015
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,015
Exercise price
Footnotes
F1, F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,991
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,991
Exercise price
$267.87
Footnotes
F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,988
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,988
Exercise price
$267.87
Footnotes
F9
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,325
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,325
Exercise price
$267.87
Footnotes
F10
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,325
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,325
Exercise price
$267.87
Footnotes
F11
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,245
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,245
Exercise price
Footnotes
F1, F12
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,486
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,486
Exercise price
$481.82
Footnotes
F13
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,864
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,864
Exercise price
$481.82
Footnotes
F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F2

Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F3

Options to purchase 1,809 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 1,808 shares vest on 8/15/2025.

Footnote F4

Options to purchase 2,500 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.

Footnote F5

Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.

Footnote F6

Fully exercisable.

Footnote F7

On 8/7/2022, the Board of Directors certified vesting of 2,363 performance shares.

Footnote F8

Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.

Footnote F9

Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.

Footnote F10

Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.

Footnote F11

Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.

Footnote F12

Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F13

Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .